Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast.

Sagara Y, Julia W, Golshan M, Toi M.

Front Oncol. 2017 Aug 28;7:192. doi: 10.3389/fonc.2017.00192. eCollection 2017. Review.

2.

Breast Cancer Screening in Low- and Middle-Income Countries: A Perspective From Malawi.

Gutnik LA, Matanje-Mwagomba B, Msosa V, Mzumara S, Khondowe B, Moses A, Kohler RE, Carey LA, Lee CN, Gopal S.

J Glob Oncol. 2015 Dec 23;2(1):4-8. doi: 10.1200/JGO.2015.000430. eCollection 2016 Feb. No abstract available.

3.

Sociological Transition and Breast Cancer in the Arab World: the Experience of Lebanon

A Lakkis N, Adib SM, Hamadeh G, El Jarrah R, H Osman M.

Asian Pac J Cancer Prev. 2017 May 1;18(5):1357-1364.

4.

Breast Cancer Screening in Patients With Newly Diagnosed Lung and Colorectal Cancer: A Population-Based Study of Utilization.

Sadigh G, Carlos RC, Ward KC, Switchenko JM, Jiang R, Applegate KE, Duszak R Jr.

J Am Coll Radiol. 2017 Jul;14(7):900-910. doi: 10.1016/j.jacr.2017.01.022. Epub 2017 Mar 17.

5.

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.

Elshof LE, Schaapveld M, Rutgers EJ, Schmidt MK, de Munck L, van Leeuwen FE, Wesseling J.

Breast Cancer Res. 2017 Mar 9;19(1):26. doi: 10.1186/s13058-017-0819-4.

6.

Contribution of the Unified Health Care System to mammography screening in Brazil, 2013.

Freitas-Junior R, Rodrigues DC, Corrêa RD, Peixoto JE, de Oliveira HV, Rahal RM.

Radiol Bras. 2016 Sep-Oct;49(5):305-310.

7.

Comparative Multifractal Analysis of Dynamic Infrared Thermograms and X-Ray Mammograms Enlightens Changes in the Environment of Malignant Tumors.

Gerasimova-Chechkina E, Toner B, Marin Z, Audit B, Roux SG, Argoul F, Khalil A, Gileva O, Naimark O, Arneodo A.

Front Physiol. 2016 Aug 9;7:336. doi: 10.3389/fphys.2016.00336. eCollection 2016.

8.

Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers.

de Munck L, de Bock GH, Otter R, Reiding D, Broeders MJ, Willemse PH, Siesling S.

Br J Cancer. 2016 Aug 23;115(5):517-24. doi: 10.1038/bjc.2016.226. Epub 2016 Aug 4.

9.

Methodologic approaches to evaluating new highly sensitive diagnostic tests: avoiding overdiagnosis.

de Groot JA, Naaktgeboren CA, Reitsma JB, Moons KG.

CMAJ. 2016 Jul 4. pii: cmaj.150999. [Epub ahead of print] No abstract available.

10.

The challenges in defining and measuring diagnostic error.

Zwaan L, Singh H.

Diagnosis (Berl). 2015 Jun;2(2):97-103. Epub 2015 Mar 12.

12.

Factors related to breast cancer detection mode and time to diagnosis in Alberta, Canada: a population-based retrospective cohort study.

Yuan Y, Li M, Yang J, Elliot T, Dabbs K, Dickinson JA, Fisher S, Winget M.

BMC Health Serv Res. 2016 Feb 19;16:65. doi: 10.1186/s12913-016-1303-z.

13.

Mammography, Martin Yaffe, and me: response and appreciation.

Kaniklidis C.

Curr Oncol. 2015 Oct;22(5):e404-8. doi: 10.3747/co.22.2883. No abstract available.

14.

Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them.

Etzioni R, Gulati R.

J Natl Cancer Inst. 2015 Nov 18;108(3). pii: djv345. doi: 10.1093/jnci/djv345. Print 2016 Mar. Review.

15.

Family physicians' intention to support women in making informed decisions about breast cancer screening with mammography: a cross-sectional survey.

Kiyang LN, Labrecque M, Doualla-Bell F, Turcotte S, Farley C, Cionti Bas M, Blais J, Légaré F.

BMC Res Notes. 2015 Nov 10;8:663. doi: 10.1186/s13104-015-1608-8.

16.

Mammography screening in less developed countries.

Li J, Shao Z.

Springerplus. 2015 Oct 15;4:615. doi: 10.1186/s40064-015-1394-8. eCollection 2015. Review.

17.

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.

Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, Wender R; American Cancer Society.

JAMA. 2015 Oct 20;314(15):1599-614. doi: 10.1001/jama.2015.12783. Erratum in: JAMA. 2016 Apr 5;315(13):1406.

18.

The role of communication in breast cancer screening: a qualitative study with Australian experts.

Parker LM, Rychetnik L, Carter SM.

BMC Cancer. 2015 Oct 19;15:741. doi: 10.1186/s12885-015-1749-0.

19.

Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies.

Jung S, Wang M, Anderson K, Baglietto L, Bergkvist L, Bernstein L, van den Brandt PA, Brinton L, Buring JE, Eliassen AH, Falk R, Gapstur SM, Giles GG, Goodman G, Hoffman-Bolton J, Horn-Ross PL, Inoue M, Kolonel LN, Krogh V, Lof M, Maas P, Miller AB, Neuhouser ML, Park Y, Robien K, Rohan TE, Scarmo S, Schouten LJ, Sieri S, Stevens VL, Tsugane S, Visvanathan K, Wilkens LR, Wolk A, Weiderpass E, Willett WC, Zeleniuch-Jacquotte A, Zhang SM, Zhang X, Ziegler RG, Smith-Warner SA.

Int J Epidemiol. 2016 Jun;45(3):916-28. doi: 10.1093/ije/dyv156. Epub 2015 Aug 28.

20.

Framing overdiagnosis in breast screening: a qualitative study with Australian experts.

Parker LM, Rychetnik L, Carter S.

BMC Cancer. 2015 Aug 28;15:606. doi: 10.1186/s12885-015-1603-4.

Supplemental Content

Support Center